{"links": [{"rel": "self", "href": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project"}, {"rel": "datasets", "href": "https://nihr.opendatasoft.com/api/v2/catalog/datasets"}, {"rel": "records", "href": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/records"}, {"rel": "exports", "href": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/exports"}, {"rel": "facets", "href": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/facets"}, {"rel": "attachments", "href": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/attachments"}], "dataset": {"visibility": "domain", "fields": [{"name": "data_source", "description": "Value is either \u201cMRC\u201d or \u201cNIHR PROG\u201d", "annotations": {}, "label": "\ufeffDATA_SOURCE", "type": "text"}, {"name": "funder_programme", "description": "For MRC: either MRC Siebel (e.g. response modes awards, projects, programmes etc.) or MRC LIS (e.g. MRC Units and Institutes)/For NIHR, funding programmes are listed below****", "annotations": {}, "label": "FUNDER_PROGRAMME", "type": "text"}, {"name": "funder_ref", "description": "Funders' unique ID for the award", "annotations": {}, "label": "FUNDER_REF", "type": "text"}, {"name": "title", "description": "Title of the project", "annotations": {}, "label": "TITLE", "type": "text"}, {"name": "abstract", "description": "Abstract/Technical Abstract", "annotations": {}, "label": "ABSTRACT", "type": "text"}, {"name": "summary", "description": "Summary/Research Summary", "annotations": {}, "label": "SUMMARY", "type": "text"}, {"name": "mrc_aimsandobjs", "description": "MRC only: Aims and Objectives", "annotations": {}, "label": "MRC_AIMSANDOBJS", "type": "text"}, {"name": "mrc_keywords", "description": "MRC only: keywords", "annotations": {}, "label": "MRC_KEYWORDS", "type": "text"}, {"name": "nihr_calltext", "description": "NIHR (NETSCC) only: call text", "annotations": {}, "label": "NIHR_CALLTEXT", "type": "text"}, {"name": "research_organsiation", "description": "Name of Research Organisation or Contractor", "annotations": {}, "label": "RESEARCH_ORGANSIATION", "type": "text"}, {"name": "ro_postcode", "description": "Research Organisation Postcode", "annotations": {}, "label": "RO_POSTCODE", "type": "text"}, {"name": "ro_country", "description": "Research Organisation Country", "annotations": {}, "label": "RO_COUNTRY", "type": "text"}, {"name": "startdate", "description": "Award Start Date", "annotations": {"facetsort": "-count", "timeserie_precision": "day"}, "label": "STARTDATE", "type": "date"}, {"name": "enddate", "description": "Award End date", "annotations": {"facetsort": "-count", "timeserie_precision": "day"}, "label": "ENDDATE", "type": "date"}, {"name": "award_value", "description": "Value of Award, GBP. Note that MRC and NIHR awards may be costed differently", "annotations": {}, "label": "AWARD_VALUE", "type": "text"}, {"name": "hrcs_health_category", "description": "Health Categories (HC) as defined by the UKCRC Health Research Classification System (HRCS)", "annotations": {}, "label": "HRCS_HEALTH CATEGORY", "type": "text"}, {"name": "hrcs_rac", "description": "Research Activity Codes (RAC) as defined by the UKCRC Health Research Classification System (HRCS)", "annotations": {}, "label": "HRCS_RAC", "type": "text"}, {"name": "con_ti_rdcount", "description": "Count of search term matches in the title of this award for search phrases for rare disease constructs***", "annotations": {}, "label": "CON_TI_RDcount", "type": "double"}, {"name": "con_ti_rdlist", "description": "Search term matches in the title of this award for search phrases for rare disease constructs, delimited by a \u2018pipe\u2019 symbol: \u2018|\u2019**", "annotations": {}, "label": "CON_TI_RDlist", "type": "text"}, {"name": "con_tiab_rdcount", "description": "Count of search term matches in the title and abstract/summary of this award for search phrases for rare disease constructs***", "annotations": {}, "label": "CON_TIAB_RDcount", "type": "double"}, {"name": "con_tiab_rdlist", "description": "Search term matches in the main text fields* of this award for search phrases for rare disease constructs, delimited by semicolon+space", "annotations": {}, "label": "CON_TIAB_RDlist", "type": "text"}, {"name": "indi_ti_rdcount", "description": "Count of search term matches in the title of this award for search phrases for individual rare disease names***", "annotations": {}, "label": "INDI_TI_RDcount", "type": "double"}, {"name": "indi_ti_rdlist", "description": "Search term matches in the title of this award for search phrases for individual rare disease names, delimited by semicolon+space", "annotations": {}, "label": "INDI_TI_RDlist", "type": "text"}, {"name": "indi_tiab_rdcount", "description": "Count of search term matches in the title and abstract/summary of this award for search phrases for individual rare disease names***", "annotations": {}, "label": "INDI_TIAB_RDcount", "type": "double"}, {"name": "indi_tiab_rdlist", "description": "Search term matches in the main text fields* of this award for search phrases for individual rare disease names, delimited by semicolon+space", "annotations": {}, "label": "INDI_TIAB_RDlist", "type": "text"}, {"name": "sum_tiab", "description": "Sum of the search term matches to the main text fields for constructs and for individual names", "annotations": {}, "label": "SUM_TIAB", "type": "double"}, {"name": "orphanet_grouping", "description": "Mapped Orphanet Grouping i.e. Rare renal disease; Rare hematologic disease; Rare circulatory system disease etc. where applicable.", "annotations": {}, "label": "ORPHANET_GROUPING", "type": "text"}, {"name": "nihr_programmestream", "description": "NIHR: Programme stream, i.e. commissioned, researcher-led or trainee development", "annotations": {}, "label": "NIHR_PROGRAMMESTREAM", "type": "text"}, {"name": "mrc_grant_category", "description": "MRC: Grant Category", "annotations": {}, "label": "MRC_Grant Category", "type": "text"}, {"name": "mrc_grant_type", "description": "MRC: Grant type", "annotations": {}, "label": "MRC_Grant type", "type": "text"}, {"name": "mrc_funding_mode", "description": "MRC: Funding Mode", "annotations": {}, "label": "MRC_Funding Mode", "type": "text"}, {"name": "mrc_strategic_criteria", "description": "MRC: Strategic Criteria", "annotations": {}, "label": "MRC Strategic Criteria", "type": "text"}, {"name": "mrc_call", "description": "MRC: Call", "annotations": {}, "label": "MRC_Call", "type": "text"}, {"name": "included_in_5_year_analysis", "description": "Yes indicates whether an award was included in the analysis in the Rare Disease Landscape project report, which included awards active between 1 April 2016 and 31 March 2021", "annotations": {}, "label": "INCLUDED_ IN_5_YEAR_ANALYSIS", "type": "text"}], "dataset_id": "rare-diseases-research-landscape-project", "dataset_uid": "da_e148nz", "has_records": true, "features": ["timeserie", "analyze"], "attachments": [{"id": "annex_3_list_of_rare_diseases_constructs_csv", "title": "Annex 3 list of rare diseases constructs.csv", "mimetype": "text/csv", "url": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/attachments/annex_3_list_of_rare_diseases_constructs_csv"}, {"id": "annex_2_list_of_search_terms_for_individual_rare_diseases_csv", "title": "Annex 2 list of search terms for individual rare diseases.csv", "mimetype": "text/csv", "url": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/attachments/annex_2_list_of_search_terms_for_individual_rare_diseases_csv"}, {"id": "rare_disease_research_joint_protocol_final_for_open_data_docx_pdf", "title": "Rare_disease_research joint_protocol FINAL for open data.docx.pdf", "mimetype": "application/pdf", "url": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/attachments/rare_disease_research_joint_protocol_final_for_open_data_docx_pdf"}, {"id": "dataset_6_lifearc_rare_disease_research_portfolio_xlsx", "title": "Dataset 6 - LifeArc rare disease research portfolio.xlsx", "mimetype": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet", "url": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/attachments/dataset_6_lifearc_rare_disease_research_portfolio_xlsx"}, {"id": "dataset_5_industry_research_and_development_r_d_projects_on_rare_diseases_in_the_uk_xlsx", "title": "Dataset 5 - Industry research and development (R&D) projects on rare diseases in the UK.xlsx", "mimetype": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet", "url": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/attachments/dataset_5_industry_research_and_development_r_d_projects_on_rare_diseases_in_the_uk_xlsx"}, {"id": "dataset_4_nihr_clinical_research_network_supported_studies_xlsx", "title": "Dataset 4 - NIHR Clinical Research Network supported studies.xlsx", "mimetype": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet", "url": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/attachments/dataset_4_nihr_clinical_research_network_supported_studies_xlsx"}, {"id": "dataset_3_nihr_infrastructure_schemes_supported_studies_xlsx", "title": "Dataset 3 - NIHR infrastructure schemes supported studies.xlsx", "mimetype": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet", "url": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/attachments/dataset_3_nihr_infrastructure_schemes_supported_studies_xlsx"}, {"id": "dataset_2_nihr_programmes_mrc_combined_includes_rare_neoplastic_rare_infectious_xlsx", "title": "Dataset 2 - NIHR Programmes & MRC combined - includes rare neoplastic & rare infectious.xlsx", "mimetype": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet", "url": "https://nihr.opendatasoft.com/api/v2/catalog/datasets/rare-diseases-research-landscape-project/attachments/dataset_2_nihr_programmes_mrc_combined_includes_rare_neoplastic_rare_infectious_xlsx"}], "alternative_exports": [], "data_visible": true, "metas": {"default": {"title": "NIHR Rare Diseases Research Landscape Project Dataset", "description": "<p class=\"\" dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">These datasets and protocols are published on behalf of the Department of Health and Social Care, who have the written agreement of the named organisations. They are to be considered in conjunction with the Rare Diseases Research Landscape Project report - found here </span><a href=\"https://openresearch.nihr.ac.uk/documents/3-45\" style=\"font-family: sans-serif; font-size: 0.875rem; background-color: rgb(255, 255, 255); text-decoration: none;\"><span style=\"font-size: 11pt; font-family: Arial, sans-serif; color: rgb(17, 85, 204); font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; text-decoration-line: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space-collapse: preserve;\">https://openresearch.nihr.ac.uk/documents/3-45</span></a>.<span style=\"font-family: Arial, sans-serif; font-size: 11pt; white-space-collapse: preserve;\"> </span></p><p><span style=\"font-family: Arial, sans-serif; font-size: 11pt; white-space-collapse: preserve;\"><br></span></p><p><span style=\"font-family: Arial, sans-serif; font-size: 11pt; white-space-collapse: preserve;\">Please note: These are static datasets created for the purpose of this project, and there are currently no plans to update these datasets.</span><br></p><p><span style=\"font-size: 11pt; font-family: Arial, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; vertical-align: baseline; white-space-collapse: preserve;\">The primary data set shown in the table is <b>Dataset 1</b>:</span><span style=\"font-size: 11pt; font-family: Arial, sans-serif; font-weight: 700; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; vertical-align: baseline; white-space-collapse: preserve;\"> NIHR Programmes &amp; MRC combined\u00a0</span><br></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">It contains MRC and NIHR programme funding for research on rare diseases, from April 2016 \u2013 March 2022. Using the filter tool on the left-hand side menu, it is possible to filter this dataset to only display awards in the 5-year period that were analysed in the report. See report Section 3.</span></p><p><b style=\"font-weight:normal;\"><br></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">The dataset includes columns with data relating to Orphanet, Health Research Classification System (HRCS) Health Categories and Research Activity Codes (RAC). For additional information see report Sections 3.2 and 3.3.</span></p><p><b style=\"font-weight:normal;\"><br></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">Orphanet - report Section 3.2 and </span><a href=\"https://www.orpha.net/consor/cgi-bin/index.php\" style=\"text-decoration:none;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#1155cc;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">https://www.orpha.net/consor/cgi-bin/index.php</span></a><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">\u00a0</span></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">HRCS Health Categories and RAC - report Section 3.3 and\u00a0 </span><a href=\"https://hrcsonline.net/\" style=\"text-decoration:none;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#1155cc;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">https://hrcsonline.net/</span></a><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">\u00a0</span></p><p><b style=\"font-weight:normal;\"><br></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">There are a further five datasets which are all available as attachments at the bottom of this web-page:</span></p><p><b style=\"font-weight:normal;\"><br></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">Please note: Datasets 1, 2 and 4 are for an extended 6-year period (to March 2022), whereas the data analysed in the report focuses on a 5-year period (to March 2021), unless stated otherwise.</span></p><p><b style=\"font-weight:normal;\"><br></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><b><span style=\"font-size: 11pt; font-family: Arial, sans-serif; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Dataset 2: </span><span style=\"font-size: 11pt; font-family: Arial, sans-serif; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">NIHR Programmes &amp; MRC combined </span></b><font face=\"Arial, sans-serif\"><span style=\"font-size: 14.6667px; white-space-collapse: preserve;\"><b>(includes rare neoplastic diseases and rare infectious diseases)</b></span></font></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">The portfolio of MRC and NIHR programme funding for research on rare diseases as was defined for the report, from April 2016 \u2013 March 2022\u00a0 (noting that for the majority of the analysis in the report, data from the 2021-22 financial year was not included). This dataset </span><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">includes</span><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\"> awards assigned to the \u2018rare neoplastic diseases\u2019 and \u2018rare infectious diseases\u2019 Orphanet groupings, which were not analysed as part of the report. See report Section 2.1.1.</span></p><p><b style=\"font-weight:normal;\"><br></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><b><span style=\"font-size: 11pt; font-family: Arial, sans-serif; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Dataset 3: </span><span style=\"font-size: 11pt; font-family: Arial, sans-serif; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">NIHR </span><span style=\"font-size: 11pt; font-family: Arial, sans-serif; color: rgb(34, 34, 34); background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">infrastructure schemes </span><span style=\"font-size: 11pt; font-family: Arial, sans-serif; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">supported studies</span></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">The portfolio of NIHR funding that supports the physical facilities in which research is delivered and the workforce within those facilities that support the research delivery. This dataset only includes NIHR Coordinating Centre Infrastructure studies supported in the financial year 2020/2021. See report Section 3.6.1.</span></p><p><b style=\"font-weight:normal;\"><br><br></b><b><span style=\"font-size: 11pt; font-family: Arial, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; vertical-align: baseline; white-space-collapse: preserve;\">Dataset 4: </span><span style=\"font-size: 11pt; font-family: Arial, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; vertical-align: baseline; white-space-collapse: preserve;\">NIHR Clinical Research Network supported studies</span><br></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">The portfolio of NIHR funding that </span><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">invests in research expertise, specialist facilities, a research delivery workforce and support services which support and deliver research</span><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">. This dataset includes CRN supported studies that were open to recruitment April 2016 \u2013 March 2022 (noting that data from the 2021-22 financial year was not included in the report analyses). See report Section 3.6.2.</span></p><p><b style=\"font-weight:normal;\"><br></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:700;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">Dataset 5: Industry research and development (R&amp;D) projects on rare diseases in the UK (1 April 2016 \u2013 1 April 2021)</span></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">This dataset contains the industry R&amp;D projects on rare diseases (not including rare infectious or rare neoplastic diseases) in the UK (1 April 2016 \u2013 1 April 2021) that were sourced from the commissioned search of Clarivate\u2019s Cortellis Competitive Intelligence dataset, and is </span><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#222222;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">made available on an as-is basis. </span><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">See report Section 4.1.</span></p><p><b style=\"font-weight:normal;\"><br></b></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:700;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">Dataset 6:</span><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\"> </span><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:700;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">LifeArc rare disease research portfolio</span></p><p dir=\"ltr\" style=\"line-height:1.3800000000000001;margin-top:0pt;margin-bottom:0pt;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">This dataset contains information about the projects that LifeArc identified in their</span><a href=\"https://www.lifearc.org/funding/rare-disease-research-funding/philanthropic-fund/\" style=\"text-decoration:none;\"><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\"> </span></a><span style=\"font-size:11pt;font-family:Arial,sans-serif;color:#000000;background-color:#ffffff;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;\">portfolio that were related to rare disease research in the 2016-2021 time-frame (not including projects on rare infectious or rare neoplastic diseases). See report paragraph 4.2.3.8.</span></p><p><br><span style=\"font-size: 11pt; font-family: Arial, sans-serif; background-color: transparent; font-weight: 700; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; vertical-align: baseline; white-space-collapse: preserve;\">Protocol:</span><span style=\"font-size: 11pt; font-family: Arial, sans-serif; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; vertical-align: baseline; white-space-collapse: preserve;\"> This is the protocol that was developed by the Project Group to </span><span style=\"font-size: 11pt; font-family: Arial, sans-serif; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; vertical-align: baseline; white-space-collapse: preserve;\">perform a detailed search of the entire NIHR and MRC portfolios, to identify research funding relevant to rare diseases. This protocol is explained in Annex 1 of the report. There are 5 annexes associated with this protocol in total. Annexes 1, 4 and 5 are in the protocol. </span><span style=\"font-size: 11pt; font-family: Arial, sans-serif; font-weight: 700; font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; vertical-align: baseline; white-space-collapse: preserve;\">Annexes 2 and 3 are provided here as separate csv files.</span><br></p>", "theme": ["Multiple Funders Data", "Curated Portfolio", "Project Dataset"], "keyword": ["Rare Diseases", "Multiple Funders Data"], "license": "Open Government Licence v3.0", "license_url": "http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "language": "en", "metadata_languages": ["en"], "timezone": null, "modified": "2026-02-23T14:33:33.319000+00:00", "modified_updates_on_metadata_change": true, "modified_updates_on_data_change": false, "data_processed": "2023-09-11T11:26:10.098000+00:00", "metadata_processed": "2026-02-23T14:33:35.008000+00:00", "geographic_reference": null, "geographic_reference_auto": false, "territory": null, "geometry_types": null, "bbox": null, "publisher": "DHSC", "references": null, "records_count": 787, "attributions": null, "source_domain": null, "source_domain_title": null, "source_domain_address": null, "source_dataset": null, "shared_catalog": null, "federated": false, "parent_domain": null, "update_frequency": null}}}}